期刊文献+

影响肝门部胆管癌预后的临床病理学因素分析 被引量:2

Analysis of factors influencing prognosis of patients with hilar cholangiocarcinoma after resection
下载PDF
导出
摘要 目的:分析影响肝门部胆管癌术后预后的因素。方法:对1997~2003年经手术切除的临床病例资料齐全的86例肝门部胆管癌患者进行研究,选择可能影响预后的8个临床病理学因素,将其对总体生存时间的影响进行单因素分析,并通过Cox比例风险模型进行多因素分析。结果:单因素分析显示,淋巴结转移(χ2=7.968,P=0.005)、肿瘤组织学分级(χ2=7.576,P=0.023)和神经浸润(χ2=5.504,P=0.019)影响肝门部胆管癌的预后;Cox风险比例模型多因素分析结果显示,淋巴结转移和神经浸润是影响肝门部胆管癌切除术后预后的独立因素。结论:影响肝门部胆管癌患者切除术后预后的独立因素是淋巴结转移和神经浸润。 OBJECTIVE: To analyse the factors which influence the prognosis of patients with hilar cholangiocarcinoma after resection. METHODS: The clinical data of 86 patients with hilar cholangiocarcinoma receiving resection in our hospital from 1997 to 2003 were collected retrospectively and the clinicopathological factors that might influence overall survival were analysed. A multivariate analysis was performed through Cox proportional hazard model. RESULTS: The single factor analysis showed that the major significant factors influencing the survival of these patients were histological type of the cancer(Х^2=7.576,P=0.023), lymph node metastasis (Х^2= 7. 968,P=0. 005), and perineural infiltration(Х^2= 5. 504,P= 0. 019). Lymph node metastasis and perineural infiltration were found to be the independent factors influencing the overall survival by multivariate analysis through the Cox model. CONCLUSION: The most important prognostic factors for hilar holangiocarcinoma after resection are lymph node metastasis, and perineural infiltration.
出处 《中华肿瘤防治杂志》 CAS 2008年第15期1173-1175,1200,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 胆管肿瘤/外科学 比例危险度模型 预后 bile duct neoplasms/surgery proportional hazards nodels prognosis
  • 相关文献

参考文献18

  • 1Patel T. Worldwide trends in mortality from biliary tract malignancies[J]. BMC Cancer,2002,2(5) : 10-14. 被引量:1
  • 2Patel T. Increasing incidnce and mortality of primary intrahepatic cholangiocarcinoma in the United States[J]. Hepatology, 2001,33(6):1353-1357. 被引量:1
  • 3Hsing A W. Rising incidence of biliary tract cancers in Shanghai [J].China Int J Cancer, 1998,75(3):368-370. 被引量:1
  • 4周宁新,黄志强.肝处胆道癌全国调查1098例分析[J].中华外科杂志,1990,28(9):516-520. 被引量:157
  • 5Shinchi H, Takao S, Nishida H, et al. Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilarcholangiocarcinoma [J].J Surg Oncol,2000,75(2): 89-95. 被引量:1
  • 6Reed D N Jr, Vitale G C, Martin R, et al. Bile duct carcinoma: trends in treatment in the nineties[J]. Am Surg,2000,66(8) : 711-715. 被引量:1
  • 7Lygidakis N J, Sgourakis G J, Dedcmadi G V, et al. Long-term results following resectional surgery for Klatskin tumors. A twenty-year personal experience [J]. Hepatogastroenterology, 2001, 48(37) :95-99. 被引量:1
  • 8Born P, Rosch T, Bruhl K, et al. Long-term outcome in patients with advanced hilarbileduct tumors undergoing palliative endoscopic orpercutaneous drainage[J]. Gastroenterol, 2000,38 (6):483-488. 被引量:1
  • 9周宁新,黄志强,冯玉泉,顾万清,蔡守旺,张文智,黄晓强,段云鹏,王敬,纪文斌.肝门部胆管癌103例外科治疗远期疗效的评析[J].中华外科杂志,1997,35(11):649-653. 被引量:110
  • 10Yoshida T, Matsumoto T, Sasaki A, et al. Lymphatic spread differs according to tumor location in extrahepatic bile duct cancer[J]. Hepatogastroenterology, 2003, 50(49):17-20. 被引量:1

二级参考文献32

  • 1王学铭.钙依粘附蛋白和神经细胞粘附分子的结构与功能[J].生命的化学,1995,15(2):18-20. 被引量:7
  • 2李维华,中华外科杂志,1993年,31卷,536页 被引量:1
  • 3黄志强,中华外科杂志,1990年,28卷,522页 被引量:1
  • 4周宁新,中华外科杂志,1990年,28卷,516页 被引量:1
  • 5Malik I A,Aziz Z.Prospective evaluation of efficacy and toxicity of 5-fu and folinic acid (Mayo Clinic regimen) in patients with advanced cancer of the gallbladder[J].Am J Clin Oncol,2003,26 (2):124-126. 被引量:1
  • 6K.Kobayashi,A.Tsuji,S.Morita,et al.A phase Ⅱ study of 5-FU(CVI) and low-dose consecutive CDDP(LFP) therapy in advanced gallbladder carcinoma[C].ASCO Annual Meeting Proceedings,2005,23 (16s):372s. 被引量:1
  • 7Malka D,Boige V,Dromain C,et al.Biliary tract neoplasms:update 2003[J].Curr Opin Oncol,2004,16(4):364-371. 被引量:1
  • 8Rajagopalan V,Daines W P,Grossbard M L,et al.Gallbladder and biliary tract carcinoma:A comprehensive update,Part 1[J].Oncology (Huntingt),2004,18(7):889-896 被引量:1
  • 9Daines W P,Rajagopalan V,Grossbard M L,et al.Gallbladder and biliary tract carcinoma:A comprehensive update,Part 2[J].Oncology (Huntingt),2004,18(8):1049-1059. 被引量:1
  • 10Kubicka S.Cholangiocellular and gallbladder carcinoma[J].Z Gastroenterol,2004,42(5):397-402. 被引量:1

共引文献266

同被引文献29

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部